Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166968 | SCV000217789 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001711449 | SCV000526560 | likely benign | not provided | 2020-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000463235 | SCV000558452 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166968 | SCV000903398 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000463235 | SCV001261061 | uncertain significance | Ataxia-telangiectasia syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000430989 | SCV001448353 | likely benign | not specified | 2020-11-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000430989 | SCV002065643 | likely benign | not specified | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000430989 | SCV004242546 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589813 | SCV005083938 | benign | Familial cancer of breast | 2024-06-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004552928 | SCV004717712 | likely benign | ATM-related disorder | 2023-04-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |